Sulfapyridine
Specifications
144-83-2CAS Number
205-642-7EC Number
4-amino-N-pyridin-2-ylbenzenesulfonamideIUPAC Name
C11H11N3O2SChemical Formula
249.29 g/molMolecular Weight
sulfapyridine; 144-83-2; Sulphapyridine; 2-Sulfapyridine; 2-Sulfanilamidopyridine; Coccoclase; Dagenan; Eubasin; Piridazol; Sulfidin; Sulfidine; Streptosilpyridine; Eubasinum; Haptocil; Plurazol; Pyriamid; Pyridazol; 2-Sulfanilylaminopyridine; Relbapiridina; Septipulmon; Thioseptal; Adiplon; Trianon; Ronin; Sulfapiridina; 2-Sulfanilamidopyridin; N-2-Pyridylsulfanilamide; Solfapiridina; Sulfapyridinum; Benzenesulfonamide, 4-amino-N-2-pyridinyl-; 4-amino-N-pyridin-2-ylbenzenesulfonamide; N(sup 1)-2-Pyridylsulfanilamide; 2-(p-Aminobenzenesulphonamido)pyridine; 2-Sulfanilyl aminopyridine; 4-amino-N-pyridin-2-yl-benzenesulfonamide; 4-(2-Pyridinylsulfonyl)aniline; M&B 693; M+B 693; 4-amino-N-(pyridin-2-yl)benzene-1-sulfonamide; 4-[(2-Pyridylamino)sulfonyl]aniline; Sulfanilamide, N1-2-pyridyl-; A-499; DTXSID3026067; N(1)-Pyridylsulfanilamide; N(1)-2-Pyridylsulfanilamide; Sulfanilamide, N(sup 1)-2-pyridyl-; 4-Amino-N,2-pyridinylbenzenesulfonamide; NSC-4753; Y5V2N1KE8U; NSC-41791; CHEBI:132842; DTXCID206067; Sulphapyridin; 4-((2-Pyridylamino)sulfonyl)aniline; Sulfanilamidopyridine; Concord 693; RefChem:58273; J01EB04; M&B693; 205-642-7; 4-amino-N-(pyridin-2-yl)benzenesulfonamide; N1-2-Pyridylsulfanilamide; 2-(4-Aminobenzenesulfonamido)pyridine; N(sup1)-Pyridylsulfanilamide; Sulfapyridine-13C6; Sulfasalazine EP Impurity J; M + B 693; NSC 4753; NSC 41791; 4-AMINO-N-2-PYRIDINYLBENZENESULFONAMIDE; 4-amino-n-(2-pyridinyl)benzenesulfonamide; MFCD00038036; MLS000069725; A 499; NSC4753; NCGC00016408-01; CAS-144-83-2; SMR000058213; Solfapiridina [DCIT]; WLN: T6NJ BMSWR DZ; 4-amino-N-(2-pyridyl)benzenesulfonamide; Sulfapyridinum [INN-Latin]; Sulfapiridina [INN-Spanish]; 2-Sulfanilamidopyridin [German]; M and B 693; [(4-aminophenyl)sulfonyl]-2-pyridylamine; 4-Amino-n-2-pyridinyl-benzenesulfonamide; SR-01000000207; N'-2-Pyridylsulfanilide; EINECS 205-642-7; Sulfapyridine (USP/INN); UNII-Y5V2N1KE8U; ulfapyridine; AI3-01049; Sulfapyridine [USP:INN:BAN]; sulfapyridine III; Sulfapyridine CRS; SFY; ALBB-006215; Prestwick_1015; Spectrum_000996; Sulfapyridine (Dagenan); Sulfapyridine (Standard); Prestwick0_000762; Prestwick1_000762; Prestwick2_000762; Prestwick3_000762; Spectrum2_001323; Spectrum3_001773; Spectrum4_000346; Spectrum5_001182; SULFAPYRIDINE [MI]; CHEMBL700; Epitope ID:122235; EC 205-642-7; SULFAPYRIDINE [INN]; cid_5336; Sulfapyridine, >=99.0%; Oprea1_344996; SCHEMBL44219; BSPBio_000804; BSPBio_003265; KBioGR_000751; KBioSS_001476; AO-801/41077453; DivK1c_000216; SPECTRUM1500551; SULFAPYRIDINE [MART.]; SPBio_001445; SPBio_002743; SULFAPYRIDINE [USP-RS]; SULFAPYRIDINE [WHO-DD]; BPBio1_000886; orb1226254; orb1310311; orb3025064; SCHEMBL29438089; BDBM39340; GECHUMIMRBOMGK-UHFFFAOYSA-; GTPL12698; HMS500K18; HY-B0212R; KBio1_000216; KBio2_001476; KBio2_004044; KBio2_006612; KBio3_002766; MSK4003; NINDS_000216; 4-(2-Pyridinylsulfonyl)aniline #; HMS1570I06; HMS1921C03; HMS2092K05; HMS2097I06; HMS2233H20; HMS3372N13; HMS3714I06; HMS5087I17; Pharmakon1600-01500551; SULFAPYRIDINE [ORANGE BOOK]; HY-B0212; NSC41791; SULFAPYRIDINE [USP IMPURITY]; Tox21_110426; aniline, N-2-pyridyl-4-sulphamoyl-; BBL007713; CCG-39261; EBC-04140; MSK4003-100M; NSC757329; s1617; SBB003154; STK292439; SULFAPYRIDINE [USP MONOGRAPH]; AKOS000121424; MSK4003-1000M; Tox21_110426_1; CS-2157; DB00891; FS27939; HS-0063; M&B-693; NSC-757329; IDI1_000216; UPCMLD0ENAT5889155:001; NCGC00016408-02; NCGC00016408-03; NCGC00016408-04; NCGC00016408-05; NCGC00016408-06; NCGC00016408-09; NCGC00016408-10; NCGC00022008-03; NCGC00022008-04; Sulfanilamide, N1-2(1H)-pyridylidene-; AC-26818; SBI-0051525.P003; SULFAPYRIDINE MELTING POINT STANDARD; DB-042750; AB00052100; NS00000225; ST45026614; EN300-21145; Sulfapyridine 1000 microg/mL in Acetonitrile; Sulfapyridine Solution in Methanol, 100ug/mL; SULFASALAZINE IMPURITY J [EP IMPURITY]; D02434; Sulfapyridine Solution in Methanol, 1000ug/mL; AB00052100_14; AB00052100_15; benzenesulfonamide, 4-amino-N(S)-(2-pyridyl)-; F358283; Sulfapyridine, VETRANAL(TM), analytical standard; Q3976827; SR-01000000207-2; SR-01000000207-3; BRD-K41406082-001-05-5; BRD-K41406082-001-09-7; BRD-K41406082-001-15-4; BRD-K41406082-001-16-2; Z104492884; 4-amino-N-(1,2-dihydropyridin-2-ylidene)benzenesulfonamide; Sulfapyridine, European Pharmacopoeia (EP) Reference Standard; 4-Amino-N-(pyrimidin-2-yl) benzenesulfonamide (Sulfadiazine) (14); Sulfapyridine, United States Pharmacopeia (USP) Reference Standard; Sulfapyridine Melting Point Standard, United States Pharmacopeia (USP) Reference Standard; InChI=1/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14); Sulfapyridine melting point standard, Pharmaceutical Secondary Standard; Certified Reference MaterialSynonyms
